MULLER, ILARIA
MULLER, ILARIA
Dipartimento di Scienze Cliniche e di Comunità
Increased risk of Thyroid Eye Disease following Covid-19 Vaccination
2024 I. Muller, D. Consonni, E. Crivicich, F. Di Marco, N. Currò, M. Salvi
Subacute thyroiditis in the SARS-CoV-2 era: a multicentre prospective study
2024 S. De Vincentis, S. Loiacono, E. Zanni, R. Sueri, M.L. Monzani, D. Santi, I. Muller, F. Di Marco, E. Crivicich, M. Armenti, U. Pagotto, L. Tucci, C. Cecchetti, T. Trenti, V. Pecoraro, G. Canu, M. Simoni, G. Brigante
Alemtuzumab-induced thyroid eye disease successfully treated with a single low-dose of rituximab
2024 I. Muller, S. Maioli, M. Armenti, L. Porcaro, N. Currò, E. Iofrida, L. Pignataro, J. Manso, C. Mian, J. Geginat, M. Salvi
Response to Letter to the Editor from Lui et al: 'Increased risk of Thyroid Eye Disease following Covid-19 Vaccination
2023 I. Muller, D. Consonni, E. Crivicich, F. di Marco, N. Currò, M. Salvi
Thyroid findings in pediatric and adult patients with PTEN hamartoma tumor syndrome: A retrospective analysis, and literature review
2023 D. Milani, A. Dolci, I. Muller, M.A. Pavesi, L. Runza, E. Kuhn, F. Natacci, B. Peissel, M.T. Ricci, L. Despini, G. Tomasello, F. Grossi, O. Garrone, D. Gambini
Clinical and Visual Outcomes of Dysthyroid Optic Neuropathy after Surgical Orbital Decompression
2023 N. Currò, C. Guastella, G. Pirola, B. Calonghi, A. Bottari De Castello, M.C. Fazio, S. Di Benedetto, V. Minorini, M. Daga, A. Contarino, I. Muller, M. Arosio, F. Viola, L. Pignataro, M. Salvi
SARS-COV-2 specific t-cells in patients with thyroid disorders related to COVID-19 are enriched in the thyroid and acquire a tissue-resident memory phenotype
2023 Y. Silvestri, F. Clemente, G. Moschetti, S. Maioli, E. Carelli, A. Espadas de Arias, R. Torelli, E. Longhi, T. De Feo, M. Crosti, M.L. Sarnicola, M. Salvi, G. Mantovani, M. Arosio, M. Bombaci, E. Pesce, R. Grifantini, S. Abrignani, J. Geginat, I. Muller
Long-term outcome of thyroid abnormalities in patients with severe Covid-19
2023 I. Muller, A. Daturi, M. Varallo, T.E. Re, D. Dazzi, S. Maioli, E. Crivicich, F. Di Marco, V. Longari, B. Dazzi, M. Castellani, G. Mantovani, M. Arosio, M. Salvi
Endocrine and multiple sclerosis outcomes in patients with autoimmune thyroid events in the alemtuzumab CARE-MS studies
2023 C.M. Dayan, B. Lecumberri, I. Muller, S. Ganesananthan, S.F. Hunter, K.W. Selmaj, H. Hartung, E.K. Havrdova, C.C. Laganke, T. Ziemssen, B. Van Wijmeersch, S.G. Meuth, D.H. Margolin, E.M. Poole, D.P. Baker, P.A. Senior
Gut microbiome associated with Graves' disease and Graves' orbitopathy: the INDIGO* multi-centre European study
2023 F. Biscarini, G. Masetti, I. Muller, H.L. Verhasselt, D. Covelli, G. Colucci, L. Zhang, M.S. Draman, O. Okosieme, P. Taylor, C. Daumerie, M. Burlacu, M. Marinò, D.G. Ezra, P. Perros, S. Plummer, A. Eckstein, M. Salvi, J.R. Marchesi, M. Ludgate
La gestione degli eventi avversi endocrini
2022 I. Muller, G. Carosi, M. Arosio
Microbiota Alterations in Patients with Autoimmune Thyroid Diseases: A Systematic Review
2022 N. Sawicka-Gutaj, D. Gruszczyński, N. Zawalna, K. Nijakowski, I. Muller, T. Karpiński, M. Salvi, M. Ruchała
Editorial: Mechanisms and Novel Therapies in Graves' Orbitopathy: Current Update
2022 H. Zhou, I. Muller, K.K. Chong, M. Ludgate, S. Fang
Therapy With Different Dose Regimens of Rituximab in Patients With Active Moderate-To-Severe Graves’ Orbitopathy
2022 I. Campi, G. Vannucchi, I. Muller, E. Lazzaroni, N. Currò, M. Dainese, B. Montacchini, D. Covelli, C. Guastella, L. Pignataro, L. Fugazzola, M. Arosio, M. Salvi
Case Report: A Novel ARMC5 Germline Mutation in a Patient with Primary Bilateral Macronodular Adrenal Hyperplasia and Hypogammaglobulinemia
2022 W. Vena, V. Morelli, M. Carrabba, F. Elli, G. Fabio, I. Muller, C. Lucca, M.A. Maffini, A.G. Lania, G. Mantovani, M. Arosio
Expression of endogenous putative tsh binding protein in orbit
2021 M.S. Draman, F. Grennan-Jones, P. Taylor, I. Muller, S. Evans, A. Haridas, D.S. Morris, D.A. Rees, C. Lane, C. Dayan, L. Zhang, M. Ludgate
Efficacy profile and safety implications of very low dose Rituximab in patients with graves' orbitopathy
2021 G.M. Vannucchi, I. Campi, D. Covelli, N. Curro, E. Lazzaroni, A. Palomba, D. Soranna, A. Zambon, L. Fugazzola, I. Muller, C. Guastella, M. Salvi
CATS II long-term anthropometric and metabolic effects of maternal sub-optimal thyroid function in offspring and mothers
2020 I. Muller, P.N. Taylor, R.M. Daniel, C. Hales, A. Scholz, T. Candler, R.J. Pettit, W.D. Evans, D. Shillabeer, M.S. Draman, C.M. Dayan, H.K.C. Tang, O. Okosieme, J.W. Gregory, J.H. Lazarus, D.A. Rees, M.E. Ludgate
New insights into the pathogenesis and nonsurgical management of Graves orbitopathy
2020 P.N. Taylor, L. Zhang, R.W.J. Lee, I. Muller, D.G. Ezra, C.M. Dayan, G.J. Kahaly, M. Ludgate
Controlled Antenatal Thyroid Screening II : Effect of Treating Maternal Suboptimal Thyroid Function on Child Behavior
2020 C. Hales, P.N. Taylor, S. Channon, K. Mcewan, A. Thapar, K. Langley, I. Muller, M.S. Draman, C. Dayan, J.W. Gregory, O. Okosieme, J.H. Lazarus, D.A. Rees, M. Ludgate